These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34189863)

  • 1. Estimating the epidemic consequences of HIV prevention gaps among key populations.
    Mishra S; Silhol R; Knight J; Phaswana-Mafuya R; Diouf D; Wang L; Schwartz S; Boily MC; Baral S
    J Int AIDS Soc; 2021 Jul; 24 Suppl 3(Suppl 3):e25739. PubMed ID: 34189863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantifying the Evolving Contribution of HIV Interventions and Key Populations to the HIV Epidemic in Yaoundé, Cameroon.
    Silhol R; Baral S; Bowring AL; Mukandavire C; Njindam IM; Rao A; Schwartz S; Tamoufe U; Billong SC; Njoya O; Zoung-Kanyi Bissek AC; Calleja JMG; Vickerman P; Mishra S; Boily MC
    J Acquir Immune Defic Syndr; 2021 Apr; 86(4):396-405. PubMed ID: 33234807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV epidemic appraisals for assisting in the design of effective prevention programmes: shifting the paradigm back to basics.
    Mishra S; Sgaier SK; Thompson LH; Moses S; Ramesh BM; Alary M; Wilson D; Blanchard JF
    PLoS One; 2012; 7(3):e32324. PubMed ID: 22396756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating the contribution of key populations towards the spread of HIV in Dakar, Senegal.
    Mukandavire C; Walker J; Schwartz S; Boily MC; Danon L; Lyons C; Diouf D; Liestman B; Diouf NL; Drame F; Coly K; Muhire RSM; Thiam S; Diallo PAN; Kane CT; Ndour C; Volz E; Mishra S; Baral S; Vickerman P
    J Int AIDS Soc; 2018 Jul; 21 Suppl 5(Suppl Suppl 5):e25126. PubMed ID: 30033604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The disconnect between individual-level and population-level HIV prevention benefits of antiretroviral treatment.
    Baral S; Rao A; Sullivan P; Phaswana-Mafuya N; Diouf D; Millett G; Musyoki H; Geng E; Mishra S
    Lancet HIV; 2019 Sep; 6(9):e632-e638. PubMed ID: 31331822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified social ecological model: a tool to guide the assessment of the risks and risk contexts of HIV epidemics.
    Baral S; Logie CH; Grosso A; Wirtz AL; Beyrer C
    BMC Public Health; 2013 May; 13():482. PubMed ID: 23679953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strengthening the HIV prevention cascade to maximise epidemiological impact in eastern Zimbabwe: a modelling study.
    Pickles M; Gregson S; Moorhouse L; Dadirai T; Dzamatira F; Mandizvidza P; Maswera R; Museka T; Schaefer R; Skovdal M; Thomas R; Tsenesa B; Mugurungi O; Nyamukapa C; Hallett TB
    Lancet Glob Health; 2023 Jul; 11(7):e1105-e1113. PubMed ID: 37349036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The human immunodeficiency virus epidemic in India. Current magnitude and future projections.
    Bollinger RC; Tripathy SP; Quinn TC
    Medicine (Baltimore); 1995 Mar; 74(2):97-106. PubMed ID: 7891548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories.
    Foreman KJ; Marquez N; Dolgert A; Fukutaki K; Fullman N; McGaughey M; Pletcher MA; Smith AE; Tang K; Yuan CW; Brown JC; Friedman J; He J; Heuton KR; Holmberg M; Patel DJ; Reidy P; Carter A; Cercy K; Chapin A; Douwes-Schultz D; Frank T; Goettsch F; Liu PY; Nandakumar V; Reitsma MB; Reuter V; Sadat N; Sorensen RJD; Srinivasan V; Updike RL; York H; Lopez AD; Lozano R; Lim SS; Mokdad AH; Vollset SE; Murray CJL
    Lancet; 2018 Nov; 392(10159):2052-2090. PubMed ID: 30340847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health Economics Research on Non-surgical Biomedical HIV Prevention: Identifying Gaps and Proposing a Way Forward.
    Torres-Rueda S; Terris-Prestholt F; Gafos M; Indravudh PP; Giddings R; Bozzani F; Quaife M; Ghazaryan L; Mann C; Osborne C; Kavanagh M; Godfrey-Faussett P; Medley G; Malhotra S
    Pharmacoeconomics; 2023 Jul; 41(7):787-802. PubMed ID: 36905570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating the contribution of key populations towards HIV transmission in South Africa.
    Stone J; Mukandavire C; Boily MC; Fraser H; Mishra S; Schwartz S; Rao A; Looker KJ; Quaife M; Terris-Prestholt F; Marr A; Lane T; Coetzee J; Gray G; Otwombe K; Milovanovic M; Hausler H; Young K; Mcingana M; Ncedani M; Puren A; Hunt G; Kose Z; Phaswana-Mafuya N; Baral S; Vickerman P
    J Int AIDS Soc; 2021 Jan; 24(1):e25650. PubMed ID: 33533115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reductions in HIV incidence are likely to increase the importance of key population programmes for HIV control in sub-Saharan Africa.
    Garnett GP
    J Int AIDS Soc; 2021 Jul; 24 Suppl 3(Suppl 3):e25727. PubMed ID: 34189844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rewriting the narrative of the epidemiology of HIV in sub-Saharan Africa.
    Baral S; Phaswana-Mafuya N
    SAHARA J; 2012; 9(3):127-30. PubMed ID: 23237066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review of post-migration acquisition of HIV among migrants from countries with generalised HIV epidemics living in Europe: mplications for effectively managing HIV prevention programmes and policy.
    Fakoya I; Álvarez-del Arco D; Woode-Owusu M; Monge S; Rivero-Montesdeoca Y; Delpech V; Rice B; Noori T; Pharris A; Amato-Gauci AJ; del Amo J; Burns FM
    BMC Public Health; 2015 Jun; 15():561. PubMed ID: 26085030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling the HIV epidemic among MSM in the United Kingdom: quantifying the contributions to HIV transmission to better inform prevention initiatives.
    Punyacharoensin N; Edmunds WJ; De Angelis D; Delpech V; Hart G; Elford J; Brown A; Gill N; White RG
    AIDS; 2015 Jan; 29(3):339-49. PubMed ID: 25686682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modelling in concentrated epidemics: informing epidemic trajectories and assessing prevention approaches.
    Boily MC; Shubber Z
    Curr Opin HIV AIDS; 2014 Mar; 9(2):134-49. PubMed ID: 24468893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Past dynamics of HIV transmission among men who have sex with men in Montréal, Canada: a mathematical modeling study.
    Milwid RM; Xia Y; Doyle CM; Cox J; Lambert G; Thomas R; Mishra S; Grace D; Lachowsky NJ; Hart TA; Boily MC; Maheu-Giroux M
    BMC Infect Dis; 2022 Mar; 22(1):233. PubMed ID: 35255860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.
    Johnson WD; Diaz RM; Flanders WD; Goodman M; Hill AN; Holtgrave D; Malow R; McClellan WM
    Cochrane Database Syst Rev; 2008 Jul; (3):CD001230. PubMed ID: 18646068
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.